Health Robotics Wins Quick Dismissal of McKesson Corporation's Lawsuit in United States Federal Court

BOZEN, Sud-Tirol, Italy, August 5, 2011 /PRNewswire/ --

Health Robotics S.r.l. today revealed that it had won a swift dismissal of McKesson's previously announced lawsuit against the company http://www.mckesson.com/en_us/McKesson.com/About%2BUs/Newsroom/Press%2BReleases%2BArchives/2011/McKesson%2Bto%2BSeek%2BDiscontinuation%2Bof%2BStrategic%2BAgreement.html in a decision announced this week by U.S. Magistrate Judge Joseph C. Spero for the Northern District of California (Case Number C-11-00728 JCS), without the case even needing discovery, hearings, and/or case management phases.

"This McKesson dismissal resolves all pending and past litigation against Health Robotics in the United States of America with a 100% winning record in our favor. As a small European company, we are indeed very pleased to see our motion to dismiss McKesson Corporation's lawsuit granted by the Court, similarly than we had successfully defeated every past attempt by other third parties to engage Health Robotics S.r.l in groundless American lawsuits," stated Gaspar DeViedma, Health Robotics' Executive Vice President.

About Health Robotics S.r.l.:

Founded in 2006, Health Robotics is the undisputed global leading supplier of life-critical intravenous medication robots, winning 100% of all worldwide IV Robot's publicly announced purchases over the past 18 months, and providing over 200 hospital installations in 6 continents with robotics-based technology and software automation solutions. Health Robotics' world-leading solutions CytoCare® and i.v.STATION® ONCO [hazardous IVs], i.v.STATION® [non-hazardous IVs], i.v.SOFT® [workflow engine for manual compounding], MEDarchiver® [life-critical clinical information system], and TPNstation® [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' products help hospitals eliminate life-threatening drug and diluent exchange errors, decrease other medical mistakes and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and pharmacy staff. For more information, please visit: http://www.health-robotics.com

For specific requests, please contact:

Claudia Flaim, Marketing Coordinator
[email protected]
+39-0471-200-372

SOURCE Health Robotics